Avella Specialty Pharmacy Again Named One of Inc. 5000’s Fastest Growing Companies

August 16, 2017| CATEGORIES: Inc 5000 , Press Release

Avella has earned this distinction for the 11th straight year, putting it in the top .1 percent of companies ever ranked by Inc. Magazine nationwide

Phoenix, AZ -- Avella Specialty Pharmacy has once again been designated one of Inc. Magazine’s 5,000 fastest growing companies in America. Avella has received this honor each of the last 11 years, validating the company’s remarkable growth over the past decade.

Wistia video thumbnail - Avella Brand Story

Thanks for reporting a problem. We'll attach technical data about this session to help us figure out the issue. Which of these best describes the problem?

Any other details or context?



This year, Avella reached number 2,680 on the Inc. 5000, based on the organization’s 3-year growth rate of 129 percent. As an 11th time honoree, Avella has joined a distinguished group of companies referred to as the “10X” club by Inc. Magazine. Only .1 percent of organizations ever ranked by the magazine have achieved this milestone. This added distinction puts Avella among a select group of companies that have not only reached incredible growth, but have also been able to sustain it over a decade or more. Avella was also the only Arizona-based company with revenue over $1B to be named to the Inc. 5000 list this year.

“Avella’s industry presence continues to expand as we penetrate new markets and develop new capabilities to better serve stakeholders across the healthcare industry. Yet we retain our core commitment to optimizing patient health as we collaborate with these partners across the care continuum,” said Rebecca M. Shanahan, CEO. “It is an honor to receive this recognition again and we are proud to be in the company of prestigious organizations in a wide array of industries.”

Inc. identified companies for this year’s list by measuring growth from 2013 to 2016. To qualify for inclusion on the list, companies must be U.S.-based, privately held, for-profit and independent (that is, not subsidiaries or divisions of other companies) as of Dec. 31, 2016. For complete results of the Inc. 5000, including company profiles and an interactive database that can be sorted by industry, region, and other criteria, visit

About Avella Specialty Pharmacy
Headquartered in Phoenix, Arizona, Avella Specialty Pharmacy is a National Accredited Specialty Pharmacy, providing individualized care and support to patients since 1996. Avella's clinical pharmacists and staff members are experts in managing complex disease states and providing compassionate care. The company offers a nationwide distribution service to complement its retail locations. In 2016, Avella was named Specialty Pharmacy of the Year by NASP, a nationally recognized pharmacy trade committee. Inc. Magazine’s 2017 list of the 5,000 fastest-growing private companies in the country included Avella for the eleventh consecutive year and also recognized Avella as the fastest-growing woman-led company in 2015. In addition, the Arizona Corporate Excellence Awards named Avella Specialty Pharmacy as the second fastest-growing private company based in the state in 2016. For more information, please visit 

About Inc.
Founded in 1979 and acquired in 2005 by Mansueto Ventures, Inc. is the only major brand dedicated exclusively to owners and managers of growing private companies, with the aim to deliver real solutions for today’s innovative company builders. Total monthly audience reach for the brand has grown significantly from 2,000,000 in 2010 to over 6,000,000 today. For more information, visit

News Alerts
If you would like to receive email updates from Avella Specialty Pharmacy, please complete the information below.
Featured Video
Photo of Brian Halligan
Path of a Specialty Prescription
The path of a specialty prescription is complex. This video details each step of the path and the unique offerings of Avella.
News Alerts
If you would like to receive email updates from Avella Specialty Pharmacy, please complete the information below.